Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Cristina Mingari

Showing results (11-20 of 149) with videos related to

Pageof 15
Sort By:
Immunology Letters|October 1, 2013
Understanding human NK cell differentiation: clues for improving the haploidentical hematopoietic stem cell transplantationElisa Montaldo, Paola Vacca, Lorenzo Moretta, et al.
Cancers|March 29, 2020
Targeted Therapies: Friends or Foes for Patient's NK Cell-Mediated Tumor Immune-Surveillance?Laura Damele, Selene Ottonello, Maria Cristina Mingari, et al.
European Journal of Immunology|April 30, 2014
Effect of tumor cells and tumor microenvironment on NK-cell functionMassimo Vitale, Claudia Cantoni, Gabriella Pietra, et al.
Frontiers in Immunology|November 9, 2018
Effect of Tyrosin Kinase Inhibitors on NK Cell and ILC3 Development and FunctionLaura Damele, Elisa Montaldo, Lorenzo Moretta, et al.
International Immunology|March 4, 2008
Methylprednisolone induces preferential and rapid differentiation of CD34+ cord blood precursors toward NK cellsChiara Vitale, Francesca Cottalasso, Elisa Montaldo, et al.
Journal of Biomedicine & Biotechnology|July 17, 2010
The emerging role of HLA-E-restricted CD8+ T lymphocytes in the adaptive immune response to pathogens and tumorsGabriella Pietra, Chiara Romagnani, Claudia Manzini, et al.
Vaccine|May 24, 2003
Human natural killer cell function and their interactions with dendritic cellsLorenzo Moretta, Guido Ferlazzo, Maria Cristina Mingari, et al.
Current Eye Research|August 3, 2010
Quantitative evaluation of ocular surface inflammation in patients with different grade of conjunctivochalasisEszter Fodor, Stefano Barabino, Elisa Montaldo, et al.
Blood|October 22, 2005
Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferationGrazia Maria Spaggiari, Andrea Capobianco, Stelvio Becchetti, et al.
Frontiers in Immunology|February 4, 2020
Exploiting Human NK Cells in Tumor TherapyPaola Vacca, Gabriella Pietra, Nicola Tumino, et al.
Pageof 15

Showing results (11-20 of 149) with videos related to

Sort By:
Pageof 15
Immunology Letters|October 1, 2013
Understanding human NK cell differentiation: clues for improving the haploidentical hematopoietic stem cell transplantationElisa Montaldo, Paola Vacca, Lorenzo Moretta, et al.
Cancers|March 29, 2020
Targeted Therapies: Friends or Foes for Patient's NK Cell-Mediated Tumor Immune-Surveillance?Laura Damele, Selene Ottonello, Maria Cristina Mingari, et al.
European Journal of Immunology|April 30, 2014
Effect of tumor cells and tumor microenvironment on NK-cell functionMassimo Vitale, Claudia Cantoni, Gabriella Pietra, et al.
Frontiers in Immunology|November 9, 2018
Effect of Tyrosin Kinase Inhibitors on NK Cell and ILC3 Development and FunctionLaura Damele, Elisa Montaldo, Lorenzo Moretta, et al.
International Immunology|March 4, 2008
Methylprednisolone induces preferential and rapid differentiation of CD34+ cord blood precursors toward NK cellsChiara Vitale, Francesca Cottalasso, Elisa Montaldo, et al.
Journal of Biomedicine & Biotechnology|July 17, 2010
The emerging role of HLA-E-restricted CD8+ T lymphocytes in the adaptive immune response to pathogens and tumorsGabriella Pietra, Chiara Romagnani, Claudia Manzini, et al.
Vaccine|May 24, 2003
Human natural killer cell function and their interactions with dendritic cellsLorenzo Moretta, Guido Ferlazzo, Maria Cristina Mingari, et al.
Current Eye Research|August 3, 2010
Quantitative evaluation of ocular surface inflammation in patients with different grade of conjunctivochalasisEszter Fodor, Stefano Barabino, Elisa Montaldo, et al.
Blood|October 22, 2005
Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferationGrazia Maria Spaggiari, Andrea Capobianco, Stelvio Becchetti, et al.
Frontiers in Immunology|February 4, 2020
Exploiting Human NK Cells in Tumor TherapyPaola Vacca, Gabriella Pietra, Nicola Tumino, et al.
Pageof 15